Quick Takeaways
- RA CAPITAL MANAGEMENT, L.P. filed SCHEDULE 13G for ACLARIS THERAPEUTICS, INC. Common Stock, $0.00001 par value per share (ACRS).
- Disclosed ownership: 6.3%.
- Date of event: 31 Mar 2026.
Quoteable Key Fact
"RA CAPITAL MANAGEMENT, L.P. disclosed 6.3% ownership in ACLARIS THERAPEUTICS, INC. Common Stock, $0.00001 par value per share (ACRS) on 31 Mar 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 6.3% | 7,626,705 | 0 | 7,626,705 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | |
| Peter Kolchinsky | 6.3% | 7,626,705 | 0 | 7,626,705 | /s/ Peter Kolchinsky | Peter Kolchinsky | |
| Rajeev Shah | 6.3% | 7,626,705 | 0 | 7,626,705 | /s/ Rajeev Shah | Rajeev Shah | |
| RA Capital Healthcare Fund, L.P. | 6.3% | 7,626,705 | 0 | 7,626,705 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager |